Try GOLD - Free

Business

BioSpectrum Asia

Upskilling and flexibility are key to staying relevant as hiring grows

With ongoing uncertainty, geopolitical tensions, and recession risks, the life sciences job market remains volatile. The year 2024 saw continued layoffs, cautious investor sentiment, and growing competition for fewer job openings. As biopharma companies restructure, hiring patterns are changing, especially at mid and senior levels. What are the current trends, and which sectors are hiring the most? Let's find out.

6 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

MedTech Disruption 2025: Startups Powering the Next Healthcare Leap

As the MedTech industry strides into 2025 and beyond, innovations are transforming the way diagnosis, treatment, and patient engagement are delivered.

7 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Dubai launches NABIDH Clinical Portal to enhance healthcare efficiency

The Dubai Health Authority (DHA) has launched a new training initiative aimed at raising awareness and boosting healthcare professionals’ capabilities in using the National Backbone for Integrated Dubai Health (NABIDH) Clinical Portal - a key component of Dubai’s digital healthcare transformation strategy.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Rznomics partners with Eli Lilly to commercialise RNA-editing therapeutics

Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered into a strategic global research collaboration and licensing agreement with Eli Lilly and Company to develop and commercialise novel RNA-editing therapies using Rznomics' proprietary trans-splicing ribozyme platform.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Illumina, OIST to accelerate genomics innovation in Japan

US-based Illumina, a global leader in DNA sequencing and array-based technologies, and the Okinawa Institute of Science and Technology (OIST), an international graduate university in Okinawa, Japan, have announced a Memorandum of Understanding (MoU) to accelerate genomics innovation in alignment with the One World, One Health framework, which recognises the interconnectedness of human, animal, and environmental health.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Japan gives nod to gene therapy for treating Duchenne Muscular Dystrophy

US-based Sarepta Therapeutics, Inc. has announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has approved ELEVIDYS (delandistrogene moxeparvovec) for the treatment of Duchenne muscular dystrophy (DMD) under the conditional and time-limited approval pathway in Japan.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

India designs breakthrough ECG lead system for enhanced diagnosis of atrial arrhythmias

Researchers at National Institute of Technology (NIT) Rourkela, India, have developed an effective upgrade to Electrocardiography (ECG), one of the most commonly used techniques to monitor heart activity.

1 min  |

BioSpectrum Asia June 2025

BioSpectrum Asia

"APAC faces a disproportionate burden of vision impairment"

World Myopia Day, a part of Myopia Awareness Week observed from May 23 to May 28, 2025, is setting new trends to raise awareness about the increasing prevalence of myopia globally.

4 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Ken Shinomiya becomes leader of Asahi Kasei's Healthcare Sector

Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, as the Leader of its Healthcare Sector succeeding Richard Packer.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

AIIB and Gavi to advance sustainable health and immunisation financing

The Asian Infrastructure Investment Bank (AIIB) and Gavi, the Vaccine Alliance have signed a landmark partnership agreement to scale and improve sustainable financing for health & immunisation systems across low-income and lower-middle-income countries.

1 min  |

BioSpectrum Asia June 2025

BioSpectrum Asia

Gene Solutions and NEWCL forge strategic partnership to advance genetic testing in Taiwan

In a groundbreaking move, Gene Solutions, a Vietnam-based startup in prenatal and oncology genetic testing space, and NEWCL Biomedical Laboratory, Taiwan's pioneering clinical laboratory with LDTs certification, have joined forces to establish an advanced Next-Generation Sequencing (NGS) laboratory in Taiwan.

1 min  |

BioSpectrum Asia June 2025

BioSpectrum Asia

India announces first-of-its-kind public funded BioFoundry at ICGEB

Addressing the \"International Centre for Genetic Engineering and Biotechnology\" (ICGEB) Board Meeting of Governors recently, Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science & Technology, Government of India, dedicated India’s first of its kind public funded DST-ICGEB ‘Bio-foundry’ in New Delhi.

1 min  |

BioSpectrum Asia June 2025

BioSpectrum Asia

Turion Labs launches in Singapore to power Southeast Asia's biotech breakthroughs

Turion Labs, a pioneering biotech venture formed by S&S LAB Korea and Future Lestari (Indonesia), has officially launched in Singapore, unveiling a transformative vision to position Southeast Asia as a global innovation engine for medical and life sciences.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

New partnership in Norway to strengthen pandemic preparedness

The Coalition for Epidemic Preparedness Innovations (CEPI) and the Norwegian Institute of Public Health (NIPH) have bolstered the long-standing relationship between the two organisations by signing a Memorandum of Understanding (MoU) during a recent meeting between NIPH’s Director General Guri Rørtveit and CEPI’s CEO Richard Hatchett.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Abbott introduces TactiFlex sensor enabled ablation catheter in India

Abbott, the global healthcare company, has announced the launch of the TactiFlex Sensor Enabled Ablation Catheter, the world's first ablation catheter with a flexible tip and contact force technology.

1 min  |

BioSpectrum Asia June 2025

BioSpectrum Asia

Cariflex opens world's largest polyisoprene latex plant in Singapore

Cariflex, the global market leader in polyisoprene rubber latex for medical-end markets and wholly owned subsidiary of DL Chemical, has officially inaugurated its new polyisoprene latex plant at Jurong Island, Singapore.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Curaleaf International launches range of medical cannabis products in Australia

American firm Curaleaf International, part of Curaleaf Holdings, Inc., has announced the launch of Curaleaf-branded products in Australia.

1 min  |

BioSpectrum Asia June 2025

BioSpectrum Asia

PAHO to fortify the Caribbean's fight against AMR

Health leaders, development partners and regional stakeholders recently gathered to launch two synergistic, landmark, regional projects under the United Kingdom (UK) Government’s Fleming Fund and jointly implemented by the Caribbean Public Health Agency (CARPHA), the Pan American Health Organization (PAHO), and the UK Health Security Agency (UKHSA).

1 min  |

BioSpectrum Asia June 2025

BioSpectrum Asia

Sonitus Medical grants BHM commercialisation rights outside of China

Sonitus Medical has entered into a strategic cooperation with BHM, a European manufacturer of bone conduction hearing devices.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Dileep Mangsuli becomes Chairman of CTSI, South Asia

Cancer Treatment Services International (CTSI) has announced the appointment of Dileep Mangsuli as Chairman.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Mark Butler steps in as Minister for Disability in Australia

Mark Butler has been appointed as Minister for Health and Ageing, and the Minister for Disability and the National Disability Insurance Scheme, following his swearing-in on May 13, 2025 as a result of Anthony Albanese's Labor government being re-elected at the 2025 Australian federal election.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Terumo takes over Wuxi Biologics' drug product plant in Germany for EUR 150 M

China-based WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has entered into an agreement with Terumo Corporation that Terumo will take over WuXi Biologics’ drug product (DP) plant in Leverkusen, Germany for EUR 150 million.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Qiagen enhances clinical genomics portfolio with acquisition of Genoox AI-powered software

Netherlands-headquartered Qiagen has signed a definitive agreement to acquire Israel-based Genoox, a provider of artificial intelligence (AI)-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Maldives and Malaysia exchange MoUs in healthcare and other sectors

An exchange of Memoranda of Understanding (MoUs), and Exchanges of Notes (EoNs) recently took place between the Government of the Republic of Maldives and the Malaysian government.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

“We are developing customised solutions aligned with India’s regulatory and market needs”

US-headquartered Agilent Technologies International has opened its first-ever India Solution Center at its LEED Platinum-certified office in Manesar, Haryana.

2 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Minghui Pharma announces oncology agreement worth $185 M with Qilu Pharma in Greater China

Minghui Pharmaceutical, a latestage clinical biopharmaceutical company, has announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical for the development, manufacturing, and commercialisation of its B7-H3 ADC (MHB088C) in Greater China (including Mainland China, Hong Kong, Macau, and Taiwan).

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

Genezen and Optieum Biotechnologies focus on CAR-T therapy for glioblastoma

Genezen, a US-based viral vector Contract Development and Manufacturing Organisation (CDMO), and Japanese startup Optieum Biotechnologies, Inc., have announced a partnership for cGMP manufacturing of the lentiviral vector (LVV) construct used in the production of OPTF01, a novel CAR-T therapy for glioblastoma treatment.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

New Zealand offers test to help more women beat ovarian cancer

New Zealand’s University of Auckland researchers are working on developing a new test that could help women access a revolutionary treatment for ovarian cancer.

1 min  |

BioSpectrum Asia June 2025
BioSpectrum Asia

BioSpectrum Asia

MUHS to pioneer Emotion-AI in Indian healthcare sector

In a landmark step toward advancing holistic healthcare, the academic wing of the Maharashtra University of Health Sciences (MUHS) in India has officially partnered with Nihilent to explore clinical applications of Emoscape, the company’s innovative AI-based emotion detection platform.

1 min  |

BioSpectrum Asia June 2025

BioSpectrum Asia

Hong Kong pioneers novel, needle-free, live-attenuated influenza vaccines

A research team led by the School of Public Health in the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the Centre for Immunology & Infection (C2i), has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV).

1 min  |

BioSpectrum Asia June 2025